Leap therapeutics reports fourth quarter and full year 2021 financial results

Cambridge, mass., march 11, 2022 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today reported financial results for the fourth quarter and year ended december 31, 2021.
LPTX Ratings Summary
LPTX Quant Ranking